Quick Answer
CHINA PHARMA HOLDINGS, INC. reported Total Revenue of $4.53 million for fiscal year 2024.
CHINA PHARMA HOLDINGS, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2024 | $4.53M | -35.4% |
| 2023 | $7.01M | -13.5% |
| 2022 | $8.10M | -15.9% |
| 2021 | $9.64M | -11.3% |
| 2020 | $10.87M | -0.5% |
| 2019 | $10.92M | -11.4% |
| 2018 | $12.33M | -6.7% |
| 2017 | $13.21M | -15.1% |
| 2016 | $15.57M | -23.5% |
| 2015 | $20.35M | -8.1% |
| 2014 | $22.13M | -32.5% |
| 2013 | $32.81M | -39.8% |
| 2012 | $54.51M | -32.8% |
| 2011 | $81.17M | +9.1% |
| 2010 | $74.39M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $756.2K | -31.3% | -26.3% |
| June 30, 2025 | $1.03M | +10.9% | -9.7% |
| March 31, 2025 | $1.14M | -17.0% | +3.3% |
| September 30, 2024 | $1.10M | -39.0% | +18.9% |
| June 30, 2024 | $924.9K | -15.8% | -32.5% |
| March 31, 2024 | $1.37M | -30.1% | -24.0% |
| September 30, 2023 | $1.80M | -8.3% | +64.3% |
| June 30, 2023 | $1.10M | -31.9% | -44.0% |
- CHINA PHARMA HOLDINGS, INC. showed a decrease of -35.4% in Total Revenue compared to the prior fiscal year.
- Over the 2010–2024 period, CHINA PHARMA HOLDINGS, INC.’s total revenue has declined by 93.9% (from $74.39 million to $4.53 million).
- The most recent figure is from CHINA PHARMA HOLDINGS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: